trending Market Intelligence /marketintelligence/en/news-insights/trending/aYirxmnQvHlaAKBWrO5lwQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

AXA Investment Managers - Real Assets buys Pfizer's French HQ

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Real Estate News & Analysis: May Edition

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


AXA Investment Managers - Real Assets buys Pfizer's French HQ

AXA Investment Managers - Real Assets completed its acquisition of the 11-story Rives de Paris office asset in Montrouge, France, from pharmaceuticals giant Pfizer in a sale and leaseback deal.

The acquisition, financial terms of which were not disclosed, was completed on behalf of AXA Selectiv' Immo, a retail fund that now manages assets worth over €2 billion on behalf of French retail investors.

Pfizer is the primary tenant of the property, which spans approximately 20,000 square meters, and has used the building as its headquarters since 2001.